Interleukin-8--a mediator of inflammatory lung disease?

PubWeight™: 0.79‹?›

🔗 View Article (PMID 1755373)

Published in Adv Exp Med Biol on January 01, 1991

Authors

D Smith1, L Burrows, J Westwick

Author Affiliations

1: Department of Pharmacology, Hunterian Institute, Royal College of Surgeons, Lincolns Inn Fields, London, U.K.

Articles by these authors

(truncated to the top 100)

Automaticity of social behavior: direct effects of trait construct and stereotype-activation on action. J Pers Soc Psychol (1996) 5.56

Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest (1990) 5.21

Effect of blood transfusions on colonic malignancy recurrent rate. Lancet (1982) 4.23

Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. J Clin Oncol (2003) 3.13

IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol (1990) 2.41

Chemokines and T lymphocytes: more than an attraction. Immunity (1998) 2.29

False positive tests for HIV in a woman with lupus and renal failure. N Engl J Med (1993) 2.23

Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22

Novel neutrophil-stimulating peptides. Immunol Today (1989) 2.16

The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol (1999) 1.81

Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest (1999) 1.46

The role of prostaglandins in rabbit monoarticular arthritis. Br J Pharmacol (1974) 1.40

Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol (1994) 1.39

Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol (2001) 1.35

The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J Biol Chem (1998) 1.34

Lymphoma of the gastrointestinal tract: prognostic guides based on 162 cases. Ann Surg (1969) 1.32

Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol (1994) 1.31

Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem Biophys Res Commun (1989) 1.30

Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur J Immunol (1993) 1.30

RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase. J Immunol (1995) 1.30

Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol (1994) 1.28

Elevation of PMN cytosolic free calcium and locomotion stimulated by novel peptides from IL-1-treated human synovial cell cultures. Biochem Biophys Res Commun (1988) 1.27

Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology (1997) 1.25

Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol (1993) 1.23

Chemokines: understanding their role in T-lymphocyte biology. Biochem J (1998) 1.22

Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol (1993) 1.21

Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg (1984) 1.21

Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi. Br J Pharmacol (1975) 1.20

beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol (1983) 1.16

Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16

Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J (Clin Res Ed) (1982) 1.16

Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut (1998) 1.15

Alternatives for vascular access for hemodialysis: experience with autogenous saphenous vein autografts and bovine heterografts. Surgery (1974) 1.14

Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health (2010) 1.12

Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem (1999) 1.11

Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J (1997) 1.11

Perioperative blood transfusion has prognostic significance for breast cancer. Surgery (1985) 1.09

Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol (1998) 1.09

Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol (1992) 1.08

Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol (1995) 1.08

Proceedings: Measurement of changes in the microvasculature. Br J Pharmacol (1976) 1.07

ADP metabolism in vascular tissue, a possible thrombo-regulatory mechanism. Thromb Res (1979) 1.07

Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int (1991) 1.05

Experience with arterial substitutes in the construction of vascular access for hemodialysis. J Cardiovasc Surg (Torino) (1980) 1.05

Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem (1997) 1.03

Microvascular responses produced by the prostaglandin endoperoxide PGG2 in vivo [proceedings]. Br J Pharmacol (1977) 1.02

Regulation and expression of chemokines: potential role in glomerulonephritis. J Leukoc Biol (1996) 1.02

Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol (1997) 0.99

Chemokines: new ligands, receptors and activities. Immunol Today (1995) 0.99

Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. Biochem Biophys Res Commun (1989) 0.98

Anatomy of pelvic arteries adjacent to the sacrospinous ligament: importance of the coccygeal branch of the inferior gluteal artery. Obstet Gynecol (1999) 0.96

Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures. Immunology (1988) 0.96

Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol (2000) 0.95

Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine (1998) 0.95

Identification of amino acid residues that form part of the ligand-binding pocket of integrin alpha5 beta1. J Biol Chem (1998) 0.95

Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg (1993) 0.94

Hematologic and immunologic aspects of parabiosis. Mt Sinai J Med (1976) 0.94

Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. Biochem J (1992) 0.94

Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Biochem Pharmacol (1984) 0.94

Listeria monocytogenes meningitis during immunosuppression. N Engl J Med (1971) 0.93

Pseudocysts of the pancreas involving the spleen. Am Surg (1982) 0.93

Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur J Immunol (1995) 0.93

Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol (1993) 0.92

C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol (1999) 0.92

An X-ray analysis of adjuvant arthritis in the rat. The effect of prednisolone and indomethacin. Agents Actions (1977) 0.91

Evaluating sensory conflict and postural instability. Theories of motion sickness. Brain Res Bull (1998) 0.91

Spontaneous rupture of the allografted kidney. Arch Surg (1971) 0.91

Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP). Thromb Res (1978) 0.90

Regulation of the extracellular ligand binding activity of integrins. Front Biosci (1998) 0.89

Rhizopus lung abscess in renal transplant patient successfully treated by lobectomy. Chest (1980) 0.89

Role of the platelet in the obliterative vascular transplant rejection phenomenon. Surg Forum (1970) 0.88

Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung. Am J Respir Cell Mol Biol (1999) 0.88

Nicotine increases intracellular calcium in rat hippocampal neurons via voltage-gated calcium channels. Neurosci Lett (1995) 0.88

IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int (1992) 0.88

Enhanced in-vivo platelet release reaction, increased thromboxane synthesis, and decreased prostacyclin release after tourniquet ischaemia. Lancet (1980) 0.88

The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules. Biochem J (1991) 0.87

Activation of protein kinase C inhibits sodium fluoride-induced elevation of human platelet cytosolic free calcium and thromboxane B2 generation. Biochem Biophys Res Commun (1986) 0.87

Antisense RNA to the c-fos gene: restoration of density-dependent growth arrest in a transformed cell line. Biochem Biophys Res Commun (1987) 0.86

Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis. Br J Pharmacol (1979) 0.86

Regional heterogeneity of endothelium-dependent vasodilatation in the rabbit kidney. J Physiol (1991) 0.86

The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings]. Br J Pharmacol (1976) 0.86

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation (1996) 0.86

Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. Br J Pharmacol (1988) 0.85

Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils. FEBS Lett (1989) 0.85

Comparison of the effects of prostaglandin analogues on rabbit platelets, rabbit isolated vascular tissues and rabbit skin microvasculature [proceedings]. Br J Pharmacol (1978) 0.85

Kaposi's sarcoma after kidney transplantation. Report of complete remission of cutaneous and visceral involvement. Transplantation (1980) 0.85

The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation. Transplantation (2001) 0.84

Problems of vascular access for haemodialysis--experience with 214 patients. Proc Eur Dial Transplant Assoc (1972) 0.84

Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. Thromb Res (1986) 0.84

Withdrawal of conclusion: false positive tests for HIV in a woman with lupus. N Engl J Med (1994) 0.84

Phorbol esters modulate thrombin-operated calcium mobilisation and dense granule release in human platelets. Biochim Biophys Acta (1986) 0.84

Inhibition of PAF-induced eosinophil accumulation in pulmonary airways of guinea pigs by anti-asthma drugs. Jpn J Pharmacol (1989) 0.84

Endothelin and cyclosporin nephrotoxicity. Lancet (1989) 0.84

Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. J Immunol (1997) 0.83

Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev (1987) 0.83

'Tis better to receive than to give: the relative failure of the African American community to provide organs for transplantation. Mt Sinai J Med (1999) 0.83

Airway inflammation induced by recombinant guinea pig tumor necrosis factor-alpha. Am J Physiol (1997) 0.83

Platelet activation during steady state sickle cell disease. J Med (1983) 0.83

Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin. Thromb Haemost (1987) 0.83

Analysis of a transformed cell line using antisense c-fos RNA. Gene (1988) 0.82